Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 2
1(20.0%)
5Total
N/A(4)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials
NCT07235345Not ApplicableEnrolling By Invitation

To Investigate the Effect of Pulmonary Surfactant With Different Inspired Oxygen Concentrations on the Clinical Outcomes of Very Preterm Infants Under Non-invasive Assisted Ventilation

Role: collaborator

NCT05955391Phase 2Active Not Recruiting

TGRX-326 Chinese Phase II for Advanced Non-small Cell Lung Cancer (NSCLC)

Role: collaborator

NCT06785714Completed

Colorectal Cancer Screening in Xinxiang City

Role: collaborator

NCT06414018Not ApplicableCompleted

Effect of Equivalent Dose of Alfentanil and Sufentanil in Bronchoscopic Treatment

Role: collaborator

NCT06527807Recruiting

Clinical Characteristics and Prognosis of Acute Stroke in Pregnancy and Puerperium

Role: collaborator

NCT06329934Not ApplicableCompleted

Refined Nursing in Rehabilitation Training

Role: lead

NCT05674214Completed

Birth Weight-discordance in Twins Pregnancy: a Multicenter Retrospective Study

Role: collaborator

NCT03903497Not ApplicableUnknown

WASP Classification in Diagnosis of Diminutive Colorectal Polyps

Role: collaborator

NCT03851497Completed

Application of Deep-learning and Ultrasound Elastography in Opportunistic Screening of Breast Cancer

Role: collaborator

All 9 trials loaded